On 5 October 2025, HRP and WHO, together with FIGO and ICM, released the new WHO Consolidated Guidelines on the Prevention, Diagnosis and Treatment of Postpartum Haemorrhage (PPH) during the Presidential Session of the FIGO World Congress.
This dissemination kit aims to raise awareness and galvanize action on preventing maternal deaths from PPH, a leading cause of maternal mortality worldwide.
Key links:
WHO Consolidated Guidelines on the Prevention, Diagnosis and Treatment of Postpartum Haemorrhage: https://bit.ly/478sRe9
Comment on new guidelines: http://bit.ly/4gRuHnf
Prognostic accuracy of clinical markers of postpartum bleeding in predicting maternal mortality or severe morbidity: http://bit.ly/4pXQIow
Simultaneous editorial to mark World Postpartum Haemorrhage Day: IJGO, BJOG and Pregnancy
Press Release: http://bit.ly/3Wnrx0R
World Postpartum Haemorrhage Day assets: https://trello.com/b/0LkXqIU4
Social assets for PPH Guideline launch:https://bit.ly/4nEWYQx
Key accounts: @HRPResearch, @WHO, @FIGO_org, @world_midwives
Key hashtags: #EndPPH #HealthForAll #HopefulFutures
📘 New WHO–FIGO–ICM Consolidated Guidelines on Postpartum Haemorrhage launched at FIGO 2025
Postpartum haemorrhage (PPH) causes around 45,000 maternal deaths each year, mostly preventable with timely care.
✅ New WHO definition of PPH
✅ 51 consolidated recommendations for prevention, diagnosis, treatment, and supportive care
✅ Key interventions include oxytocin, heat-stable carbetocin, tranexamic acid, and treatment bundles
✅ Implementation strategies: training, supplies, monitoring, and community engagement
📖 Explore the full resource: https://bit.ly/478sRe9
#EndPPH #HealthForAll #HopefulFutures
Contact: Natalie Bailey, HRP, baileyn@who.int